| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, Connecticut.
PURPOSE. Low concentrations of excitotoxic agents such as glutamate and nitric oxide decrease survival rates of purified retinal ganglion cells (RGCs). In the retina, RGCs are ensheathed by retinal Müller glial (RMG) cell processes. The purpose of this study was to determine whether RMG cells could protect RGCs from these excitotoxic injuries.
METHODS. RGCs were purified from 7- or 8-day-old Long Evans rats and cultured on polylysine/laminin-coated coverslips in serum-free medium for 2 days. The coverslips were then moved to dishes containing either confluent RMG monolayers or no glial cells in glutamate-free medium. Some dishes with confluent RMG cells were exposed to D,L-threo-ß-hydroxyaspartate (THA), a blocker of glutamate uptake. Three days after exposure to various concentrations of glutamate or the NO donor, 2,2'-(hydroxynitroso-hydrazino)bisethanamine, survival rates of RGCs were measured by calcein-acetoxymethyl ester staining. Glutamate concentrations in the medium were measured using amino acid analysis.
RESULTS. Without RMG cells, the application of increasing concentrations (5–500 µM) of glutamate caused a dose-dependent increase in RGC death after 3 days. The neurotoxic effects of glutamate were blocked in the RMG cell cocultures, even when there was no direct contact between the cell types. The protective effect of RMG cells was weakened by THA treatment. NO also had toxic effects on RGC. RMG cells prevented this toxicity but only when in direct contact with the RGCs.
CONCLUSIONS. RMG cells can protect RGCs from glutamate and NO neurotoxicity. We suggest that functional disorders of glutamate uptake in RMGs might be one of the etiologies of glaucoma.
This article has been cited by other articles:
|
|
 |
|
  G. Tezel, C. Luo, and X. Yang Accelerated Aging in Glaucoma: Immunohistochemical Assessment of Advanced Glycation End Products in the Human Retina and Optic Nerve Head Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1201 - 1211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Georges, E E Cornish, J M Provis, and M C Madigan Muller cell expression of glutamate cycle related proteins and anti-apoptotic proteins in early human retinal development Br. J. Ophthalmol., February 1, 2006; 90(2): 223 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kashiwagi, Y. Iizuka, Y. Tanaka, M. Araie, Y. Suzuki, and S. Tsukahara Molecular and Cellular Reactions of Retinal Ganglion Cells and Retinal Glial Cells under Centrifugal Force Loading Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3778 - 3786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Garcia, V. Forster, D. Hicks, and E. Vecino Effects of Muller Glia on Cell Survival and Neuritogenesis in Adult Porcine Retina In Vitro Invest. Ophthalmol. Vis. Sci., December 1, 2002; 43(12): 3735 - 3743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. G. Martin, H. Levkovitch-Verbin, D. Valenta, L. Baumrind, M. E. Pease, and H. A. Quigley Retinal Glutamate Transporter Changes in Experimental Glaucoma and after Optic Nerve Transection in The Rat Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2236 - 2243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kawasaki, M.-H. Han, J.-Y. Wei, K. Hirata, Y. Otori, and C. J. Barnstable Protective Effect of Arachidonic Acid on Glutamate Neurotoxicity in Rat Retinal Ganglion Cells Invest. Ophthalmol. Vis. Sci., June 1, 2002; 43(6): 1835 - 1842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kashiwagi, Y. Iizuka, M. Araie, Y. Suzuki, and S. Tsukahara Effects of Retinal Glial Cells on Isolated Rat Retinal Ganglion Cells Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2686 - 2694. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
